Share on LinkedInShare on LinkedIn

ARTICLE · 09 NOVEMBER 2023

New Insights Into mRNA Technologies

Boult Wade Tennant LLP
Boult Wade Tennant LLP
Contributor
Boult Wade Tennant LLP

Boult Wade Tennant LLP

Boult is a top-tier European firm specializing in IP advice and solutions for both domestic and...

View firm profile
Explore more from Boult Wade Tennant LLP

The European Patent Office (EPO) has published an insight report providing an overview of patent trends and broader information on the field of mRNA technologies (see here).

United KingdomIntellectual Property

Do you have an interest in mRNA technologies, in particular mRNA vaccines?

The European Patent Office (EPO) has published an insight report providing an overview of patent trends and broader information on the field of mRNA technologies (see here). The report provides an accessible overview of this growing field with analysis of the EPOs extensive patent data. The results will be of interest to broad stakeholders in academia and industry who are active in this exciting area.

While mRNA vaccines came to the forefront of public attention during the COVID-19 pandemic, the insight report provides on overview of the long history of mRNA technologies and how they have evolved up to the present day. The EPO's analysis of where companies and universities are focusing their efforts, particularly in the medical application category and vaccines subcategory (see Figure 13), provides fascinating insights into the parties involved and their commercial strategies. The insight

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from